Nk:io

Developer of small molecule therapies for hematological and solid tumors

placeLondon, England, United Kingdom calendar_todayFounded 2020 groups1 employees language nk-io.com

Registered entities

Investor mix

18 investors on record; lead investors include Cancer Research Horizons.

Investor typeCountShare
Venture capital422%
Angel & family office16%
Accelerator & incubator16%
Other / undisclosed1267%
Coming soon